This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Companies in this article
Rumours have emerged that French pharmaceutical giant Sanofi-Aventis is in the early stages of planning a reported $20 billion acquisition with the potential target thought to be US-based.
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.